We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




3T MRI Systems Provides Rapid, High-Resolution Imaging

By Biotechdaily staff writers
Posted on 16 May 2007
A high-field magnetic resonance 3T imaging (MRI) system is demonstrating that it is not only a research tool, but that it can also make an impact in clinical imaging.

Siemens Medical Solutions (Erlangen, Germany) recently installed its 350th 3T Magnetom Trio MRI scanner at South Jersey Radiology Associates P.A. More...
(Voorhees, NJ, USA). The scanner is one of more than 175 worldwide 3T systems that use Siemens proprietary Tim (Total imaging matrix) coil architecture, which eliminates the need for patient repositioning and manual coil changes during scans while considerably enhancing image quality.

"The Trio will allow us to advance to the next level by imaging those regions that are still problematic at 1.5 Tesla: small joints such as the wrist, forefoot, and fingers,” said William F. Muhr, Jr., M.D., a radiologist at South Jersey Radiology Associates P.A. "The 3T field strength moves our neuroimaging to the next level with diffusion tensor imaging and fiber tracking. The magnet will also benefit patients with renal impairments who cannot tolerate as much gadolinium contrast. The increased signal-to-noise ratio at 3T allows us to perform body imaging and MRA [MR angiography] at reduced contrast doses. While performing these applications, the Magnetom Trio also excels at routine knee, hip, spine, and brain imaging, allowing us to run a full patient schedule right out of the gate.”

The system meets a wide range of imaging needs, from routine clinical use, to high-end research, combining the system's fast gradients with one of the largest field-of-view acquisitions and the highest 3T magnet homogeneity. Siemens' Tim technology enables the system to handle challenges encountered with other 3T systems, without compromising image quality. The high signal-to-noise ratio of the Magnetom Trio, in combination with Tim technology, enables reduced scan times, which as a result, reduces motion artifacts, improves patient comfort, and helps increase patient throughput.

Building upon Tim technology, the T-class of the Magnetom Trio now features syngo TimCT, an advanced technology that provides continuous table movement during scanning, a process that is comparable to computed tomography (CT). This technology allows clinicians to acquire one complete planning scan, or peripheral angiography, in a single, continuous movement. The results are faster scans, increased image quality, and the potential for new application capabilities.


Related Links:
Siemens Medical Solutions

New
Gold Member
Automatic Hematology Analyzer
CF9600
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Hematology Consumables
Bioblood Devices
New
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.